Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors

Journal of Thoracic Disease

Wei Zhang¹  Tianqing Chu¹  Liwen Xiong¹  Lili Dong¹  Aiqin Gu¹  Huangping Shi¹  Shaohua Cui¹  Yizhuo Zhao¹  Yuqing Lou¹  Huimin Wang¹  Liyan Jiang¹ 

[1] Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, ChinaDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China

关键词: Epidermal growth factor receptor (EGFR);    tyrosine kinase inhibitors (TKIs);    lung adenocarcinoma;    progression-free survival (PFS);   

DOI  :  10.3978/j.issn.2072-1439.2016.01.12

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown